Colon adenocarcinoma (COAD) is among the most prevalent cancers worldwide, ranking as
the third most prevalent malignancy in incidence and mortality. The somatostatin receptor …

Eur J Clin Invest 2012; 42 (7): 777–783 Abstract Background To determine the
immunohistochemical expression levels of the somatostatin receptor subtypes 2 and 5 (Sst2 …

The clinical relevance of the somatostatin receptor subtype 2 (sst2) is well defined in
neuroendocrine tumors but it is still a matter of debate whether its expression may have a …

AIM: To study the SSTR1, 2, 3, 4, 5 expression and their relationships with clinico-
pathological factors, cell proliferation, Bcl-2 and p53 expression in colorectal cancer cells …

Somatostatin (SST)/somatotropin release-inhibiting factor (SRIF) is a well-known
neuropeptide, widely distributed in the central and peripheral nervous systems, that …

Somatostatin receptors (SSTRs) are G‑protein‑coupled plasma membrane receptors that
have been determined to be expressed in normal and cancer tissues. Activation of SSTRs …

Somatostatin receptors (SSTRs) are inhibitory G-protein coupled receptors that are
ubiquitously expressed in normal and cancer cells. Somatostatins (SST) are the natural …

Simple Summary Immunolocalization of somatostatin receptor 2 (SSTR2) could predict the
therapeutic efficacy of somatostatin analogues (SSAs) in neuroendocrine tumors (NETs) …

Background. Somatostatin receptors (SSTR1-5) are inhibitory G-protein coupled receptors
that are ubiquitously expressed in both normal and cancer cells. Activation of SSTRs results …

Aim: Somatostatin receptor subtype 2 (SSTR2) is the principal mediator of somatostatin's
(SST) antiproliferative effects on normal and cancer cells. Therefore, we investigated …